Global Investor Forum Contact

Amylon Therapeutics

The key to global disease, in a single patient

Abstract

The power of ultra-genetics, that is the vision behind Amylon Therapeutics. Diseases that are long forgotten, that are ignored or deemed uninteresting commercially – they all potentially contain incredible power and the key to solving global therapeutic challenges. The exponential growth in population and life-expectancy confront us with diseases that reach epidemic proportions at an unprecedented pace. Alzheimer’s disease, elderly blindness, stroke and many more have become unbearable burdens on society and eluded therapeutic intervention.
Targeting these disorders face challenges beyond those at a therapeutic level. Due to their sheer size and global patient distribution, clinical development has become a financial and logistical challenge that only a handful in this world can take on. But what if we could find a way to bypass these challenges? To provide an achievable alternative that alters the very basis of this system? At Amylon we believe we can.
With our ultra-genetic approach we focus on rare genetic subtypes on global disorders, in which pathological mutations cause accelerated subtypes of otherwise sporadic disorders. Focussing on these disorders allows us to bypass the challenges of large clinical trials and the uncertainty of finding the right patients and intervening at the right time.

Speaker: Thomas de Vlaam, Founder & CEO

Thomas de Vlaam is a science entrepreneur who invented Amylon's lead program AT-010. He developed the program at ProQR Therapeutics as their therapeutic area leader for CNS indications. Thomas holds an International Bachelor's degree of Medicine and Global Health from the University of Groningen.
Save the Date: 14 February 2019

Join the next edition of Innovation for Health & Global Investor Forum on 14 February 2019 in WTC Rotterdam. Gain new insights, discover new opportunities, expand your network and jointly shape the future of healthcare!

Early-bird fee (until 1 October):
Regular: € 275, excl. VAT 
Start-up/Non-profit: € 195, excl VAT
Student: € 90, excl VAT
Register here

Contribute as sponsor, speaker or exhibitor!

Do you want to capture the attention of our 800+ high-level attendees in key positions? Then join the sixth edition of Innovation for Health and benefit from the diverse sponsorship & exhibition opportunities that this conference has to offer you. Have a look at our participation brochure or contact us at +31(0)35 628 6659 to discuss the possibilities.
Download participation brochure

Global Investor Forum & I4H join forces (again)!

We are very pleased to announce that, after a succesful partnership with the Global Investor Forum last year, we will again join forces for the next edition on 14 February 2019. Last year, this partnership resulted in being the biggest venture capital forum in the Netherlands dedicated specifically to Life Sciences & Health.  More info about GIF

Sponsors & Partners
Main partner
Host sponsor
Host sponsor
Host sponsor
Platinum sponsor
Gold sponsor
Partner
Partner
Award sponsor
Your logo?
© 2018 Innovation for Health